Education & Training
- B.S. Biochemistry, B.S. Biological Sciences (Physiology and Neurobiology), University of Maryland, College Park
- M.S. Biostatistics, University of Pittsburgh
Representative Publications
Li, D., Wang, R., Liang, T., Ren, H., Park, C., Tai, C. H., Ni, W., Zhou, J., Mackay, S., Edmondson, E., Khan, J., Croix, B. S., & Ho, M. (2023). Camel nanobody-based B7-H3 CAR-T cells show high efficacy against large solid tumours. Nature communications, 14(1), 5920.
Li, D., English, H., Hong, J., Liang, T., Merlino, G., Day, C. P., & Ho, M. (2022). A novel PD-L1-targeted shark VNAR single-domain-based CAR-T cell strategy for treating breast cancer and liver cancer. Molecular therapy oncolytics, 24, 849–863.
Hong, J., Kwon, H. J., Cachau, R., Chen, C. Z., Butay, K. J., Duan, Z., Li, D., Ren, H., Liang, T., Zhu, J., Dandey, V. P., Martin, N. P., Esposito, D., Ortega-Rodriguez, U., Xu, M., Borgnia, M. J., Xie, H., & Ho, M. (2022). Dromedary camel nanobodies broadly neutralize SARS-CoV-2 variants. Proceedings of the National Academy of Sciences of the United States of America, 119(18), e2201433119.